- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.04. | CHORDATE MEDICAL HOLDING: Chordate Medical obtains trademark registration for Ozilia in the US | 2 | Cision News | ||
| 28.03. | Chordate Medical Holding AB: Year-End Report Chordate Medical Holding AB (publ) January - December 2024 | 98 | GlobeNewswire (Europe) | Summary of the period October-December 2024Net turnover was SEK 86,076 (481,597)Cash flow from operating activities was SEK -4,659,856 (-7,501,648)Profit/loss after financial items was SEK -8,529,829... ► Artikel lesen | |
| 20.02. | CHORDATE MEDICAL HOLDING: Chordate Medical's CEO on the rights issue outcome and way forward | 1 | Cision News | ||
| 06.02. | CHORDATE MEDICAL: Double celebration for Lipum | 2 | Cision News | ||
| 31.01. | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Chordate Medical Holding AB (publ) | 205 | GlobeNewswire | With effect from February 03, 2025, the unit rights in Chordate Medical Holding AB (publ) will be traded on First North Growth Market. Trading will continue up until and including February 12, 2025.
Instrument:
Unit... ► Artikel lesen | |
| 29.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 29.01.2025 | 396 | Xetra Newsboard | Das Instrument B7Z0 NO0012861667 ARRIBATEC GROUP NK 0,10 EQUITY wird ex Kapitalmassnahme gehandelt am 29.01.2025 The instrument B7Z0 NO0012861667 ARRIBATEC GROUP NK 0,10 EQUITY is traded ex capital... ► Artikel lesen | |
| 28.01. | Chordate Medical Holding AB: Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ) | 115 | GlobeNewswire (Europe) | The following resolutions was adopted at the extraordinary general meeting of Chordate Medical Holding AB (publ) held on 28 January 2025
Amendment of the articles of associationThe general meeting resolved... ► Artikel lesen | |
| 14.01. | CHORDATE MEDICAL: Chordate's study results published in Neurology | 2 | Cision News | ||
| CHORDATE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 16.12.24 | Chordate Medical's CEO looks ahead to 2025 - "The exit process is our primary focus" | 1 | Cision News | ||
| 05.11.24 | Chordate Medical Holding AB: Chordate Medical Holding (publ) Interim Report January-September 2024 | 151 | GlobeNewswire (Europe) | Summary of the period July-September 2024Net turnover was SEK 147,993 (210,947)Cash flow from operating activities was SEK -5,126,552 (-4,325,051)Profit/loss after financial items was SEK -5,681,292... ► Artikel lesen | |
| 02.09.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 02.09.2024 | 367 | Xetra Newsboard | The following instruments on XETRA do have their first trading 02.09.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.09.2024
Aktien
1 CA0467895094 ATCO Ltd. CL II
2 CA92938W8631... ► Artikel lesen | |
| 30.08.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.08.2024 | 1.227 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 30.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.08.2024ISIN NameAU000000PAN4 PANORAMIC... ► Artikel lesen | |
| 30.08.24 | XFRA ISIN CHANGE | 390 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen SE0009495559 Chordate Medical Holding AB 30.08.2024 SE0022726139 Chordate Medical Holding AB 02.09.2024 Tausch 5... ► Artikel lesen | |
| 30.08.24 | XFRA K1Z: AUSSETZUNG/SUSPENSION | 220 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCHORDATE MEDICAL... ► Artikel lesen | |
| 28.08.24 | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for Chordate Medical Holding AB | 304 | GlobeNewswire | Referring to the bulletin from Chordate Medical Holding AB's annual general
meeting, held on May 15, 2024, the company will carry out a stock reverse stock
split in relations 1:500. The share will be... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 257,00 | -6,82 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| FRESENIUS | 42,290 | +1,24 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,390 | +0,50 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 0,671 | 0,00 % | Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On? | ||
| BRIGHTSPRING HEALTH SERVICES | 23,480 | 0,00 % | IPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point | ||
| FRESENIUS MEDICAL CARE | 50,94 | +1,88 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
| ALIGNMENT HEALTHCARE | 14,910 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| NUTEX HEALTH | 158,61 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| GENEDX | 59,51 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
| HIMS & HERS HEALTH | 53,82 | -1,72 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| PROCEPT BIOROBOTICS | 54,75 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BASEL MEDICAL GROUP | 1,640 | 0,00 % | Basel Medical Group Ltd: Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia | Singapore, April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 5,820 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook | First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared... ► Artikel lesen | |
| GERRESHEIMER | 61,50 | -0,65 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Nachhaltigkeit
Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
12.05.2025... ► Artikel lesen | |
| PROGYNY | 21,860 | 0,00 % | Progyny erweitert Medizinischen Beirat um zwei renommierte Ärztinnen |
Das Unternehmen CHORDATE MEDICAL HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +11,89 % bei einem Aktienkurs von 0,922 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHORDATE MEDICAL HOLDING AB finden Sie auf Wallstreet Online.